Peruvian rainforest plants have anti-malarial activity

June 4, 2018, Elsevier

An Atlas-award winning study reported in the Journal of Ethnopharmacology has found that traditional uses of medicinal plants in the Peruvian rainforest are, to a large extent, backed up by science. Samples taken from plants identified by people from the Iquitos-Nauta road communities and studied in the lab have been found to contain extracts that are harmful to protozoan parasites responsible for malaria and other infectious conditions common in the tropics.

These new findings pave the way for the identification of promising new compounds with potential for , researchers say. Their work has been selected by an to receive this month's Atlas Award, selected from ten nominations that demonstrate the potential impact on people's lives around the world. The winning research is presented alongside interviews, expert opinions, multimedia and much more on the Atlas website.

"These people live at the edge of the city and forest so there are a lot of rural aspects to their lives," said Alexandre Maciuk of Université Paris-Saclay in France. "They interact a lot with the forest and this means that their knowledge of the forest resources is quite extensive, but being near the city, they also know quite a bit about modern medicine.

"They are not so far from the doctor, and know what malaria is; that it's a parasite. So they have this modern concept of medicine and they mix it with traditional knowledge," Dr. Maciuk added.

The research team, led in the field by Elsa Rengifo and Pedro Vásquez-Ocmín from Instituto de Investigationes de la Amazonia Peruana, surveyed 75 rural people from the province of Maynas, located in the region of Loreto, Peru, to learn which plants they traditionally used to treat malaria and 'uta' the name used for the condition called leishmaniasis. After making a list of plants named by at least five study participants, they verified and collected the plant species indicated. After carefully producing an extract from a small amount of the dried- and ground-up plants, researchers tested the ability of those extracts to harm including:

  • Plasmodium falciparum (which causes malaria);
  • Leishmania donovani (which causes leishmaniasis); and
  • Trypanosoma brucei gambiense (which causes African sleeping sickness).

From the initial list including dozens of plants, the researchers found ten with activity on P. falciparum, and 15 with activity on L. donovani. Extracts made from the leaves of a plant called Costus curvibracteatus and the bark of Grias neuberthii worked against all three parasitic species. The findings provide a list of candidates for further anti-protozoal research.

"The traditional use of and the methods used for treating these diseases is part of the richness of the mixed culture of rural mestizos," the researchers wrote. "These communities can easily share this knowledge, making it a resource that should be respected and preserved with the creation of indigenous pharmacopeias."

Explore further: Discovery of key molecules involved in severe malaria – new target for malaria vaccine

More information: Pedro Vásquez-Ocmín et al. Antiprotozoal activity of medicinal plants used by Iquitos-Nauta road communities in Loreto (Peru), Journal of Ethnopharmacology (2017). DOI: 10.1016/j.jep.2017.08.039

Related Stories

Discovery of key molecules involved in severe malaria – new target for malaria vaccine

December 4, 2017
Malaria is one of three major infectious diseases affecting approximately 300 million people every year, accounting for about 500,000 deaths, but effective vaccine development has not been successful. Among malaria parasites ...

Recommended for you

Health insurance plans may be fueling opioid epidemic

June 22, 2018
Health care insurers including Medicare, Medicaid and major private insurers have not done enough to combat the opioid epidemic, suggests a study led by researchers at Johns Hopkins Bloomberg School of Public Health.

Overdose risk quintuples with opioid and benzodiazepine use

June 22, 2018
In the first 90 days of concurrent opioid and benzodiazepine use, the risk of opioid-related overdose increases five-fold compared to opioid-only use among Medicare recipients, according to a new study from the University ...

Discovery opens door for synthetic opioids with less addictive qualities

June 1, 2018
Making opioids from sugar instead of from field grown opium poppies has the potential to solve many of the problems associated with manufacturing strong pain killers.

US doctors prescribing fewer opioid painkillers: report

May 31, 2018
US doctors reduced the number of prescriptions for opioid painkillers last year, continuing a five-year trend, in an effort to reverse a deadly drug abuse epidemic, a report released Thursday said.

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.